Fig. 1
From: BUB1 serves as a biomarker for poor prognosis in liver hepatocellular carcinoma
BUB1 expression status in various cancers, especially in HCC (LIHC,Liver hepatocellular carcinoma) (A) The expression level of BUB1 in different types of tumor tissues and normal tissues in TCGA database; (B) BUB1 mRNA expression comparison between normal and tumor tissues in the HCC; (C-H) RRM2 expression distribution analyses stratified based onhistologic grade, pathologic stage, T classification, OS event, AFP content and tumor status (Kruskal-Wallis test). (n=347,**, P < 0.01; ***, P < 0.001)